“…For example, translin binding sites at, or close to, the breakpoint junctions have been found in the neoplasia-related t(1; 14)(p32;q11), t(2;13)(q35;q14), t(8;14)(q24;q11), t(12;16)(q13;p11), and t(14;18)(q32;q21) (Aoki et al, 1995;Chalk et al, 1997;Kanoe et al, 1999;Hosaka et al, 2000). However, such sequences are very frequent in the human genome (Hosaka et al, 2000), and the presence of binding motifs close to breakpoint junctions may well be fortuitous. Enzymes have also been implicated, with binding sites for DNA topoisomerases I and II having been identified in inv(10)(q11q11) in thyroid carcinomas (Klugbauer et al, 2001) and in t(9;11)(p22;q23) in therapy-related AML (Felix et al, 1995;Atlas et al, 1998), respectively.…”